fda warning letters compounded semaglutide telehealth 2024 2025 US sends 25 to companies over claims on weight-loss drugs Beyond the Headlines: FDA Warning

This is why an honest consultation and safety screening is always essential before starting treatment

GLP-1 therapy has also shown benefit in improving atherothrombosis markers (e.g., inflammation, endothelial dysfunction, clotting in this population)

Weight loss itself produces significant sleep improvements independent of any medication effects

These are ingredient-level research findings

People need to know from the start that these are prescribed as long-term medications for their effect on body weight, glucose levels, and potentially cardiovascular protection, Pratley says, adding that people dont stop antihypertensives or statins because they achieve or reach normal blood pressure or LDL cholesterol levels, respectively

semaglutide comparison after three years of head-to-head publications in one line, it would be this: at the pivotal dose and at 60-72 weeks, the average weight loss shows a clear progression from semaglutide to retatrutide